Percheron Therapeutics【PER】銘柄情報

Percheron Therapeutics Ltd (PER) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.003

( -25.00% )

買値

0.003

売値

0.004

出来高

22,368,469

0.003 日の範囲 0.004

0.003 52 週間の範囲 0.013

時価総額

4.567M

前日終値

0.004

始値

0.004

時刻

2239969

0.003

最終取引時間

12:56:42

財務取引量

VWAP

平均取引量 (3 か月)

AUD 2,647,323

発行済株式数

1,522,412,686

配当利回り

PER

-0.46

1 株当たり利益 (EPS)

-0.01

歳入

1.74M

純利益

-9.49M

Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenn... Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

percherontx.com

本社

Melbourne, Australia

設立

2026

Percheron Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker PER. The last closing price for Percheron Therapeutics was AUD0. Over the last year, Percheron Therapeutics shares have traded in a share price range of AUD 0.003 to AUD 0.013.

Percheron Therapeutics currently has 1,522,412,686 shares in issue. The market capitalisation of Percheron Therapeutics is AUD4.57 million. Percheron Therapeutics has a price to earnings ratio (PE ratio) of -0.46.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.001	-25	0.004	0.005	0.003	7549229	0.00392346	DE
4	-0.002	-40	0.005	0.005	0.003	3229923	0.00407142	DE
12	-0.003	-50	0.006	0.006	0.003	3269183	0.00451214	DE
26	-0.006	-66.6666666667	0.009	0.01	0.003	2010436	0.00510386	DE
52	-0.006	-66.6666666667	0.009	0.013	0.003	1867394	0.00715749	DE
156	-0.055	-94.8275862069	0.058	0.14	0.003	3145384	0.0216227	DE
260	-0.055	-94.8275862069	0.058	0.14	0.003	3145384	0.0216227	DE